Paul MacLeman

Paul Donald Richard MacLeman is currently the Chairman at AdAlta Ltd., Livac Pty Ltd., Isla Pharmaceuticals, Inc., Supertrans Medical, Sypharma Pty Ltd., CMAX Clinical Research Pty Ltd., and Upkara Asia Pacific Pty Ltd. He previously held positions as the Chief Executive Officer & Head-Investor Relations at Genetic Technologies Ltd. from 2009 to 2012, Chief Executive Officer, Director & MD at Idt Australia Ltd. from 2013 to 2017, Chief Executive Officer at Hatchtech Pty Ltd., Executive Chairman at Island Pharmaceuticals Ltd. from 2020 to 2024, Director at Gtech International Resources Ltd. from 2009 to 2012, Director at Laboratoires Protec SA, Executive Director at AusCann Group Holdings Ltd. in 2019, Non-Executive Director at Nextleaf Solutions Ltd., Vice President at Agenix Ltd., and Chief Operating Officer at Imugene Ltd. He has an undergraduate degree from The University of Sydney and an MBA from Macquarie Graduate School of Management Pty Ltd.